Form D · Hedge Fund

Titan Fund I SPC - Titan Biotech Dislocation Fund SP

Stamford, CT · CIK 0001926743

Offering snapshot reported May 8, 2026 · SEC filing

Reported sold
$17.7M
Indefinite offering
Investors reported
33
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
May 1, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$8.85M$17.7MMay 13, 2022: $15,105,000.00May 13, 2022May 13, 2022: $15,105,000.00May 11, 2023: $16,505,000.00May 11, 2023May 10, 2024: $17,359,000.00May 10, 2024May 9, 2025: $17,494,000.00May 9, 2025May 8, 2026: $17,699,000.00May 8, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$17,494,000 → $17,699,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 8, 2026Amendment$17,699,000$205,000vs May 9, 202533SEC filing
May 9, 2025Amendment$17,494,000$135,000vs May 10, 202433SEC filing
May 10, 2024Amendment$17,359,000$854,000vs May 11, 202332SEC filing
May 11, 2023Amendment$16,505,000$1,400,000vs May 13, 202228SEC filing
May 13, 2022Initial$15,105,000No comparison24SEC filing
May 13, 2022Amendment$15,105,000$0vs May 13, 202224SEC filing

Offering details

Securities
Pooled investment fund, Other
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-445624
Shares. The minimum investment may be changed at the discretion of the Board of Directors but, not below the statutory minimum disclosed in Item 11.

Source: Form D, filed May 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

TITAN FUND I SPC - TITAN BIOTECH DISLOCATION FUND SP

Investment adviser: TITAN ADVISORS, LLC

Gross asset value
$58.6M
Beneficial owners
29
ADV minimum commitment
$100K

Reported in Form ADV on Jul 15, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator MUFG FUND SERVICES (CAYMAN) LIMITED GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS LLP HOUSTON, Texas, United States
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Marketer BELCO PRIVATE CAPITAL, INC. TORONTO, Canada Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

JEFFERIES LLC
SEC 8-15074

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2119996 · Jul 15, 2026 · Schedule D 7.B.(1), fund 805-6018228793

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Fox Executive, Promoter
Richard Leifels Director
Philip Lombino Director
Frank Stone Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
750 Washington Blvd. 10 Th Floor
Stamford, CT, 06901